EUCR

Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR

Delisted

EUCR was delisted on the 26th of April, 2023.

Back to rankings

34 hedge funds and large institutions have $49.6M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $
Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$19K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$783K
2
+$768K
3
+$650K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$534K
5
BCM
Basso Capital Management
Connecticut
+$325K

Top Sellers

1
-$985K
2
-$103K
3
-$98K
4
SC
Shay Capital
New York
-$69.9K
5
WAM
Wolverine Asset Management
Illinois
-$50.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$9.05M
2
$5.87M
3
$4.24M
4
$3.91M
5
$3.47M
6
$3.22M
7
$1.96M
8
$1.96M
9
$1.72M
10
$1.64M
11
$1.14M
12
$1.04M
13
$1.02M
14
$978K
15
$978K
16
$978K
17
$978K
18
$833K
19
$768K
20
$663K
21
$650K
22
$560K
23
$364K
24
$325K
25
$313K
1
2